Ozempic Face: What It Is, What Causes It and What Helps

Medically reviewed by Dr. Reina Punj, MBBS, PG Diploma in Endocrinology (University of South Wales), Lead Physician, Excelgenics Clinical Panel.

"Ozempic face" is a popular, non-medical term for the hollow, tired or older look some people notice in their face after losing a lot of weight on semaglutide or similar medicines such as tirzepatide. It is not a medical diagnosis. Current evidence suggests it is caused mainly by the weight loss itself, including loss of the fat that gives the face its fullness, rather than by a unique effect of the drug.

Since semaglutide's Indian patent expired in March 2026 and generic versions arrived, many more Indians are using these medicines. This guide covers the meaning of Ozempic face, what causes it, who notices it more, treatment options and nutrition.

What is Ozempic face? Meaning and medicines involved

Ozempic is a brand of semaglutide for type 2 diabetes, and Wegovy is a brand of semaglutide for long-term weight management; both act on the GLP-1 receptor. Mounjaro is a brand of tirzepatide, which acts on both the GIP and GLP-1 receptors. We use the generic names from here on.

"Ozempic face" describes facial changes during substantial weight loss: hollower cheeks and temples, more visible folds, and looser or sagging skin. Similar changes are described after large weight loss from bariatric (weight-loss) surgery; the term does not describe a separate medical condition.

What causes Ozempic face?

The face has pads of fat that give it shape. When you lose body fat, some comes from these pads, and if the skin above does not shrink back as quickly, hollowing and sagging can follow. Skin's ability to recoil depends on collagen and elastin. Elastin turnover falls with age and is damaged by ultraviolet (UV) light, so older or sun-damaged skin tends to adapt less well.

• Face volume falls as weight falls. A small 2025 imaging study of 20 people on GLP-1 medicines found a median 9% drop in midface volume, and about 7% of facial volume lost for every 10 kg of body weight lost.
• No proof of a face-specific drug effect. A 2024 article in the Journal of Drugs in Dermatology noted that evidence that these medicines break down facial fat more than fat elsewhere is lacking.
• Other weight loss does the same. A 2024 systematic review of massive weight loss after medicines or bariatric surgery describes loss of cheek volume and an older apparent age.

These medicines also reduce lean mass along with fat. In a STEP 1 substudy of semaglutide, about 38% of the weight lost was lean body mass, as summarised by a 2025 joint advisory from four US nutrition and obesity societies. In a SURMOUNT-1 substudy of tirzepatide, about a quarter was lean mass. Lean mass includes muscle and other non-fat tissue, not only muscle.

Who notices Ozempic face more?

Research is early and mostly reviews and small studies. Factors linked to more noticeable change include:

• Losing more weight: facial volume loss tracked weight lost in the imaging study.
• Older age: elastin turnover falls over time, so older skin may spring back less.
• Sun damage and smoking: UV light damages elastin, and the American Academy of Dermatology (AAD) says smoking greatly speeds up how quickly skin ages.

Speed of weight loss is often blamed, but we found no study that has measured its effect on the face directly.

Ozempic face before and after: what to expect

Treat "Ozempic face before and after" photos online with caution. Lighting, angle, make-up and filters change how a face looks, and the photos rarely say how much weight was lost or how fast. We found no study that has followed facial volume over the long term after people stop these medicines, so no one can predict exactly what will happen for you.

Ozempic face treatment: what may help

Discuss the pace of weight loss with your doctor

These medicines are started at a low dose and increased step by step, as prescribed. If you are worried about how fast you are losing weight, talk to the prescribing doctor; never change, skip or stop a dose yourself. We found no trial testing whether a slower pace changes how the face looks. See also weight management: why it's hard and how to do it right.

Protein and strength training

The 2025 joint advisory lists preserving muscle and bone through resistance training and an appropriate diet among its priorities for people on GLP-1 medicines, aiming for strength training at least three times a week plus at least 150 minutes of moderate aerobic exercise weekly. Protein contributes to the maintenance of muscle mass. Neither has been shown to prevent Ozempic face.

Skin care basics

• Use a broad-spectrum sunscreen of SPF 30 or higher every day, as the AAD recommends.
• Apply a facial moisturiser daily; it holds water in the skin.
• If you smoke, stop. Cleanse gently and avoid products that sting or burn.

Medical procedures

Surgical and non-surgical options exist. The AAD lists fillers such as hyaluronic acid gel (lasting about 4 to 12 months), calcium hydroxylapatite (about 6 months to a year), poly-L-lactic acid (about 1 to 3 years) and a person's own fat. Side effects include redness, swelling and bruising, and less often lumps, infection or allergic reactions, which are reported much more often when fillers are injected in non-medical settings. These are medical procedures, mentioned for information only; a qualified dermatologist can advise whether any suits you.

Nutrition for your skin while on GLP-1 medicines

With a smaller appetite, every meal counts. The 2025 advisory warns of a risk of falling short on nutrients including iron, calcium, magnesium, zinc and vitamins A, D, E, K, B1, B12 and C. No food or supplement has been tested in people on GLP-1 medicines for Ozempic face, so think of nutrition as supporting normal skin, not reversing facial change.

Protein first. ICMR-NIN's 2020 recommended dietary allowance for healthy Indian adults is 0.83 g of protein per kg of body weight a day, about 50 g for a 60 kg adult. The advisory notes that higher targets, such as 1.2–1.6 g/kg a day, have been proposed during active weight loss; ask your doctor or dietitian what suits you, especially if you have kidney disease. Vegetarian sources (from our protein rich foods guide):

Vitamin C. Vitamin C contributes to normal collagen formation for the normal function of skin. Amla, guava (amrood), capsicum (shimla mirch) and citrus fruits are rich sources; see vitamin C rich foods.

Zinc. Zinc contributes to the maintenance of normal skin, and zinc contributes to the maintenance of normal hair. Pumpkin seeds (kaddu ke beej), til, chana, rajma and dairy supply it; see zinc rich foods and collagen rich foods for skin. Our GLP-1 diet guide covers eating on these medicines in detail, and our guide to loose skin after weight loss covers the body.

Where does a collagen supplement fit?

No supplement has been tested in people taking GLP-1 medicines, and a collagen supplement does not restore lost facial volume or tighten loose skin. Most collagen skin trials used 2.5–10 g of collagen peptides a day, and a 2025 meta-analysis of 23 trials in The American Journal of Medicine found benefits mainly in industry-funded and lower-quality studies, with no significant effect in higher-quality trials.

If you want a supplement as one part of your routine, Radia Marine Collagen + Hyaluronic Acid provides, per 2-capsule daily serving, 500 mg marine collagen peptides (type I and III), 100 mg low-molecular-weight hyaluronic acid, 100 mg grape seed extract (95% OPC), 65 mg vitamin C, 60 mg CoQ10, 10 mg lycopene, 10 mg vitamin E, 5 mg zinc, 5 mg black pepper extract and 4 mg astaxanthin. Its 500 mg of collagen is well below the 2.5–10 g a day used in most collagen skin trials. It is fish-derived, so avoid it if you have a fish or seafood allergy. It contains piperine, which can affect how some medicines are processed, and CoQ10, which can interact with warfarin. Check with your doctor before using it if you take any medication (including a GLP-1 or diabetes medicine), or are pregnant or breastfeeding. See our Marine Collagen Supplements Guide, the benefits of marine collagen and our skin and beauty range.

Frequently asked questions

Does tirzepatide cause Ozempic face too?

The changes appear to be linked to weight loss rather than one drug, so any medicine or method that causes substantial weight loss can bring them. The name simply comes from a well-known brand.

Is Ozempic face permanent?

There is not enough research to say. We found no study that has tracked facial volume long term after people stop these medicines. A dermatologist can explain the options if the changes bother you.

Can a supplement or cream prevent Ozempic face?

No supplement has been tested in people on GLP-1 medicines, and none has been shown to prevent or reverse Ozempic face. Sunscreen, moisturiser, enough protein and strength training are sensible basics.

Should I stop my medicine because of facial changes?

No. Do not stop, skip or change your dose on your own. Talk to the prescribing doctor, who can weigh the benefits of the medicine against your concerns.

References

1. Carboni A, Woessner S, Martini O, Marroquin NA, Waller J. Natural weight loss or "Ozempic face": demystifying a social media phenomenon. Journal of Drugs in Dermatology. 2024;23(1):1367–1368. doi:10.36849/JDD.7613
2. Sharma RK, Vittetoe KL, Barna AJ, et al. Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngology–Head and Neck Surgery. 2025;173(2):360–366. doi:10.1002/ohn.1209
3. Jafar AB, Jacob J, Kao WK, Ho T. Soft tissue facial changes following massive weight loss secondary to medical and surgical bariatric interventions: a systematic review. Aesthetic Surgery Journal Open Forum. 2024. doi:10.1093/asjof/ojae069
4. Daneshgaran G, Shauly O, Gould DJ. "Ozempic face" in plastic surgery: a systematic review of the literature on GLP-1 receptor agonist mediated weight loss and analysis of public perceptions. Aesthetic Surgery Journal Open Forum. 2025. PMC12232544
5. Kommu S, Whitfield P. Semaglutide. In: StatPearls. StatPearls Publishing; updated 2024. ncbi.nlm.nih.gov/books/NBK603723
6. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989–1002. doi:10.1056/NEJMoa2032183
7. Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16275
8. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Clinical Nutrition. 2025;122:344–367. doi:10.1016/j.ajcnut.2025.04.023
9. Myung SK, Park Y. Effects of collagen supplements on skin aging: a systematic review and meta-analysis of randomized controlled trials. The American Journal of Medicine. 2025;138(9):1264–1277. doi:10.1016/j.amjmed.2025.04.034
10. Choi FD, Sung CT, Juhasz MLW, Mesinkovska NA. Oral collagen supplementation: a systematic review of dermatological applications. Journal of Drugs in Dermatology. 2019;18(1):9–16. jddonline.com
11. ICMR-National Institute of Nutrition. Nutrient Requirements for Indians: Recommended Dietary Allowances and Estimated Average Requirements, 2020 (brief note). nin.res.in
12. US Food and Drug Administration. Mounjaro (tirzepatide) prescribing information, revised 01/2026. accessdata.fda.gov
13. American Academy of Dermatology. Fillers: FAQs; How to select a sunscreen; 11 ways to reduce premature skin aging. aad.org

This article is for general education and is not medical advice. Food supplements are not intended to diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before starting any supplement, particularly if you are pregnant, breastfeeding, have a medical condition or take medication.